HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2432051232v1 243/2/578    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kariya, S. Articles by Sawada, S. Search for Related Content PubMed PubMed Citation Articles by Kariya, S. Articles by Sawada, S.

Primary Patency with Cutting and Conventional Balloon Angioplasty for Different Types of Hemodialysis Access Stenosis¹

¹ From the Department of Radiology, Kansai Medical University, 10-15 Fumizono, Moriguchi, Osaka 570-8507, Japan (S.K., N.T., H.K., A.K., Y.S., S.S.); and Departments of Radiology (T.S.) and Urology (T.K.), Ishikiri Seiki Hospital, Osaka, Japan. From the 2004 RSNA Annual Meeting. Received July 22, 2005; revision requested September 27; revision received December 21; accepted January 6, 2006; final version accepted September 5. Address correspondence to S.K. (e-mail: shuuji{at}ops.dti.ne.jp).

Purpose: To compare primary patency rates of cutting balloon percutaneous transluminal angioplasty (PTA) (hereafter, cutting PTA) and conventional balloon PTA (hereafter, conventional PTA) in the treatment of different types of hemodialysis access stenosis.

Materials and Methods: The institutional review board approved this study. Written informed consent was obtained for the prospective component of this study and waived for the retrospective component. Patients in whom treatment with cutting PTA alone or conventional PTA alone was clinically successful formed the two study groups. Primary patency for the lesion was defined as uninterrupted patency of the treated site after balloon PTA. A site was no longer considered patent when the patient underwent treatment for hemodialysis access failure due to restenosis of the treated site. Primary patency rates for lesions were calculated with the Kaplan-Meier method according to the type of stenosis. We compared the two groups by using the log-rank test to determine statistical significance.

Results: In the cutting PTA group, 62 patients with 77 stenoses (32 men, 30 women; mean age, 65.5 years ± 10.1 [standard deviation]) achieved clinical success. In the conventional PTA group, 52 patients with 68 stenoses (23 men, 29 women; mean age, 61.9 years ± 10.2) achieved clinical success. In patients with autogenous venous stenosis, no significant difference in the primary patency rate was noted between groups (P = .369). In patients with graft-to-vein anastomotic stenosis, the primary patency rate was significantly higher for cutting PTA than for conventional PTA (P = .39). In patients with intragraft stenosis, no significant difference in the primary patency rate was noted between groups (P = .379). In patients with in-stent restenosis, no significant difference in the primary patency rate was noted between groups (P = .923).

Conclusion: Primary patency rates are significantly higher for cutting PTA in the treatment of graft-to-vein anastomotic stenosis; however, no significant differences in primary patency rates exist between these PTAs in the treatment of autogenous venous stenosis, intragraft stenosis, or in-stent restenosis.

© RSNA, 2007